1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Asia Pacific Radioactive Tracer Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. Asia Pacific Radioactive Tracer Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Rising Prevalence of Chronic Diseases
- 5.1.2 Increased Use of Nuclear Imaging Techniques
5.2 Market Opportunities
- 5.2.1 Use of Radioactive Tracers in Cancer Diagnosis
5.3 Future Trends
- 5.3.1 Short Shelf-Life of Radioactive Tracers
- 5.3.2 Availability of Substitutes to Nuclear Diagnosti Imaging Procedures
5.4 Impact of Drivers and Restraints
6. Asia Pacific Radioactive Tracer Market Regional Analysis
6.1 Asia Pacific Radioactive Tracer Market Overview
6.2 Asia Pacific Radioactive Tracer Market Revenue 2020-2030 (US$ Million)
6.3 Asia Pacific Radioactive Tracer Market Forecast Analysis
7. Asia Pacific Radioactive Tracer Market Analysis – by Tracer Type
7.1 Technetium-99m & Tc-97m
- 7.1.1 Overview
- 7.1.2 Technetium-99m & Tc-97m: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Iodine-131
- 7.2.1 Overview
- 7.2.2 Iodine-131: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Iron-59
- 7.3.1 Overview
- 7.3.2 Iron-59: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Lutetium-171
- 7.4.1 Overview
- 7.4.2 Lutetium-171: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Rubidium Chloride & Ammonia
- 7.5.1 Overview
- 7.5.2 Rubidium Chloride & Ammonia: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Scandium-46
- 7.6.1 Overview
- 7.6.2 Scandium-46: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.7 Seaborgium-269
- 7.7.1 Overview
- 7.7.2 Seaborgium-269: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.8 Hassium-269
- 7.8.1 Overview
- 7.8.2 Hassium-269: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.9 Gallium Citrate Ga 67
- 7.9.1 Overview
- 7.9.2 Gallium Citrate Ga 67: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.10 Prostate-Specific Membrane Antigen
- 7.10.1 Overview
- 7.10.2 Prostate-Specific Membrane Antigen: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.11 FDDNP & FDOPA
- 7.11.1 Overview
- 7.11.2 FDDNP & FDOPA: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.12 Phosphorus-32 & Chromium-51
- 7.12.1 Overview
- 7.12.2 Phosphorus-32 & Chromium-51: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.13 Thallium-201
- 7.13.1 Overview
- 7.13.2 Thallium-201: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.14 F-18 FDG
- 7.14.1 Overview
- 7.14.2 F-18 FDG: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.15 F-18 FAPI
- 7.15.1 Overview
- 7.15.2 F-18 FAPI: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.16 Ga-68 FAPI
- 7.16.1 Overview
- 7.16.2 Ga-68 FAPI: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.17 F-18 PSMA
- 7.17.1 Overview
- 7.17.2 F-18 PSMA: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.18 DOTATOC/DOTANOC/DOTATATE
- 7.18.1 Overview
- 7.18.2 DOTATOC/DOTANOC/DOTATATE: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
8. Asia Pacific Radioactive Tracer Market Analysis – by Test Type
8.1 PET
- 8.1.1 Overview
- 8.1.2 PET: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
8.2 SPECT
- 8.2.1 Overview
- 8.2.2 SPECT: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific Radioactive Tracer Market Analysis – by Application
9.1 Oncology
- 9.1.1 Overview
- 9.1.2 SPECT: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
9.2 Pulmonary
- 9.2.1 Overview
- 9.2.2 SPECT: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Neurology
- 9.3.1 Overview
- 9.3.2 SPECT: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Cardiology
- 9.4.1 Overview
- 9.4.2 SPECT: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
10. Asia Pacific Radioactive Tracer Market – Asia-Pacific Analysis
10.1 Asia-Pacific
- 10.1.1 Asia Pacific Radioactive Tracer Market Breakdown, by Key
Country, 2023 and 2030 (%)
- 10.1.1.1 Asia Pacific Radioactive Tracer Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 China:
Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.1.1 China: Asia Pacific Radioactive Tracer Market Breakdown, by Tracer Type
- 10.1.1.1.2 China: Asia Pacific Radioactive Tracer Market Breakdown, by Test Type
- 10.1.1.1.3 China: Asia Pacific Radioactive Tracer Market Breakdown, by Application
- 10.1.1.2 India:
Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.2.1 India: Asia Pacific Radioactive Tracer Market Breakdown, by Tracer Type
- 10.1.1.2.2 India: Asia Pacific Radioactive Tracer Market Breakdown, by Test Type
- 10.1.1.2.3 India: Asia Pacific Radioactive Tracer Market Breakdown, by Application
- 10.1.1.3 Japan:
Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.3.1 Japan: Asia Pacific Radioactive Tracer Market Breakdown, by Tracer Type
- 10.1.1.3.2 Japan: Asia Pacific Radioactive Tracer Market Breakdown, by Test Type
- 10.1.1.3.3 Japan: Asia Pacific Radioactive Tracer Market Breakdown, by Application
- 10.1.1.4 Australia:
Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.4.1 Australia: Asia Pacific Radioactive Tracer Market Breakdown, by Tracer Type
- 10.1.1.4.2 Australia: Asia Pacific Radioactive Tracer Market Breakdown, by Test Type
- 10.1.1.4.3 Australia: Asia Pacific Radioactive Tracer Market Breakdown, by Application
- 10.1.1.5 Rest of Asia-Pacific :
Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.5.1 Rest of Asia-Pacific : Asia Pacific Radioactive Tracer Market Breakdown, by Tracer Type
- 10.1.1.5.2 Rest of Asia-Pacific : Asia Pacific Radioactive Tracer Market Breakdown, by Test Type
- 10.1.1.5.3 Rest of Asia-Pacific : Asia Pacific Radioactive Tracer Market Breakdown, by Application
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Asia Pacific Radioactive Tracer Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 Rotem Industries Ltd
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Invicro LLC
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Cardinal Health Inc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Newcastle University
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Novartis AG
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Curium
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 General Electric Co
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 IBA Radiopharma Solutions
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
14. Appendix
14.1 About Business Market Insights